1st Quarter - Report
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for SHARP CORPORATION
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Seek to exempt pharmaceutical packagers from facility fee established in the new generic drug user fee program at FDA
Foreign entity interest: N/A
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M. CLAPTON | Health Policy Dir, Senate HELP Cmte |
| KATHLEEN M MCAULIFFE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.